
Reset all filters
01 3Belmore Neidrauer LLP
02 2Blake Cassels & Graydon LLP
Reset all filters
01 22431675
02 12621273
03 22659770
Reset all filters
01 3MACITENTAN
02 2MACITENTAN | TADALAFIL
Reset all filters
01 5TABLET
Reset all filters
01 22021-12-04
02 12026-09-11
03 22027-08-28
Patent Expiration Date : 2021-12-04
Date Granted : 2011-11-08
Brand Name : OPSUMIT
Patent Number : 2431675
Filing Date : 2001-12-04
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-12-04
Date Granted : 2011-11-08
Patent Expiration Date : 2027-08-28
Date Granted : 2014-11-18
Brand Name : OPSUMIT
Patent Number : 2659770
Filing Date : 2007-08-28
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-08-28
Date Granted : 2014-11-18
Patent Expiration Date : 2026-09-11
Date Granted : 2014-07-29
Brand Name : OPSUMIT
Patent Number : 2621273
Filing Date : 2006-09-11
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-09-11
Date Granted : 2014-07-29
Patent Expiration Date : 2021-12-04
Date Granted : 2011-11-08
Brand Name : OPSYNVI
Patent Number : 2431675
Filing Date : 2001-12-04
Strength per Unit : 10mg / 40mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-12-04
Date Granted : 2011-11-08
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2027-08-28
Date Granted : 2014-11-18
Brand Name : OPSYNVI
Patent Number : 2659770
Filing Date : 2007-08-28
Strength per Unit : 10mg / 40mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-08-28
Date Granted : 2014-11-18
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF